ASTS NewsBrief
May. 19, 2014

A new way for transplant professionals to report patient safety events
HRSA
The UNet online patient safety situation reporting system is getting its first big makeover at the end of May. Over the last few years, we have watched patient safety situation reporting grow from 21 reports to the Patient Safety Portal in 2006, to 119 in 2013. Learn how the online reporting system is changing and how it will benefit all transplant professionals and patients in the long run. More

Starzl elected to National Academy of Sciences
ASTS
ASTS congratulates its first President, Thomas E. Starzl, MD, PhD, on his election to the National Academy of Sciences. Dr. Starzl performed the first successful liver transplant in 1967 and has had a long and distinguished research career as well.More

ASTS Pioneer Award Recipient announced
ASTS
This year's ASTS Pioneer Award Recipient is Mark A. Hardy, MD, the 21st President of ASTS. He also received the Francis Moore Excellence in Mentorship in the Field of Transplantation Surgery Award in 2010. The award will be presented along with the ASTS Research Grants at the World Transplant Congress on Monday, July 28, at 10 a.m.More

We need your help to meet our goal!
ASTS
The ASTS Foundation Fund the Future Campaign has a goal of raising $100,000 to fund research grants by June 30. We need your help! Please consider donating any amount.More

Risk of antibody-mediated rejection in kidney transplant recipients with anti-HLA-C donor-specific antibodies
American Journal of Transplantation (login required)
Anti-HLA donor-specific antibodies cause acute and chronic antibody-mediated rejection. However, the clinical relevance of anti-HLA-C antibodies remains unclear. We evaluated the clinical relevance of the presence of anti-HLA-C DSA at day 0 in renal transplant recipients. In this retrospective, case-controlled study, 608 patients who underwent kidney transplantation between August 2008 and March 2012 were screened for the presence of isolated anti-HLA-C DSA at day 0. More

Pioneer genome scientist trying to fix transplant issue with pig organs
Reuters via Business Insider
Genome pioneer J. Craig Venter is teaming up with a unit of United Therapeutics Corp to develop pig lungs that have been genetically altered to be compatible with humans, a feat that, if successful, could address the urgent need for transplant organs for people with end-stage lung disease.More

Medication adherence in the transition of adolescent kidney transplant recipients to the adult care
Pediatric Transplantation (login required)
Non-adherence is common in adolescent and young adult kidney transplant recipients, leading to adverse graft outcomes. The aim of this study was to determine whether adherence to immunosuppressant medications changes during transition from a pediatric to an adult program within the same transplant center. Adherence was assessed for a period of two yr before and two year after the transfer.More

Study: Clinical features and outcomes of influenza infections in lung transplant recipients
Transplant Infectious Disease (login required)
For lung transplant recipients influenza infections pose a considerable risk for complications. These infections have mainly been described in hospitalized patients. The aim of this study was to describe characteristics of predominantly outpatient-treated influenza infections. More

Biliary complications after orthotopic liver transplantation
Current Opinion in Organ Transplantation (login required)
The potential advantages of machine perfusion are very promising as it may provide better protection of the vulnerable bile ducts against ischemia–reperfusion injury. Clinical trials will be needed to demonstrate the impact of machine perfusion in reducing the incidence of biliary complications, especially NAS, after OLT.More

Outcome of organs procured from donors on extracorporeal membrane oxygenation (ECMO) support: An analysis of kidney and liver allograft data
Clinical Transplantation (login required)
ECMO has become rescue therapy for adults with overwhelming cardiac and/or respiratory failure. Not all patients are saved, creating a new cohort of potential organ donors. This study examines the outcomes of liver and kidney allografts procured from donors on ECMO.More